Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Paul G. Richardson, Albert Oriol, Meral Beksaç, +157

The Lancet Oncology

Hematological MalignancyMedicineHematologyMyeloid NeoplasiaPharmacotherapy +4

ALK+, CD30−, CD20− Large B-Cell Lymphoma Containing Anaplastic Lymphoma Kinase (ALK) Fused to Clathrin Heavy Chain Gene (CLTC)

Norio Chikatsu, Hiroshi Kojima, Kazumi Suzukawa, +5

Modern Pathology

Hematological MalignancyLymphoid NeoplasiaOncologyMedicineCancer Cell Biology +5

Dasatinib Is an Effective Treatment for Angioimmunoblastic T-cell Lymphoma

Tran B. Nguyen, Mamiko Sakata‐Yanagimoto, Manabu Fujisawa, +20

Cancer Research

Detection of the circulating tumor DNAs in angioimmunoblastic T- cell lymphoma

Mamiko Sakata‐Yanagimoto, Rie Nakamoto-Matsubara, Daisuke Komori, +10

Annals of Hematology

Lymphoid NeoplasiaMedicineMalignant Blood DisorderHematologyImmunology +9

Identification of a novel fusion gene <i>MLL‐MAML2</i> in secondary acute myelogenous leukemia and myelodysplastic syndrome with inv(11)(q21q23)

Noriko Nemoto, Kazumi Suzukawa, Seiichi Shimizu, +7

Genes Chromosomes and Cancer

Clinicopathological features and prognostic factors of Japanese patients with “peripheral T-cell lymphoma, unspecified” diagnosed according to the WHO classification

Hiroshi Kojima, Yuichi Hasegawa, Kazumi Suzukawa, +12

Leukemia Research

Prognostic FactorsLymphoid NeoplasiaSurgical PathologyImmunologyWho Classification +5

Role of phosphatidylinositol-3 kinase and its association with Gab1 in thrombopoietin-mediated up-regulation of platelet function

Hiroshi Kojima, Atsushi Shinagawa, Seiichi Shimizu, +3

Experimental Hematology

InflammationThrombosisThrombopoiesisSignal TransductionBlood Platelet +13

Results of Venetoclax and Azacitidine Combination in Chemotherapy Ineligible Untreated Patients with Acute Myeloid Leukemia with <i>IDH 1/2</i> Mutations

Daniel A. Pollyea, Courtney D. DiNardo, Martha Arellano, +13

Blood

Quantification of mRNA in Whole Blood by Assessing Recovery of RNA and Efficiency of cDNA Synthesis

Masato Mitsuhashi, Shigeru Tomozawa, Katsuya Endo, +1

Clinical Chemistry

Adherence to the standard dose of imatinib, rather than dose adjustment based on its plasma concentration, is critical to achieve a deep molecular response in patients with chronic myeloid leukemia

Chikashi Yoshida, Takuya Komeno, Mitsuo Hori, +16

International Journal of Hematology

Hematological MalignancyChronic Myeloid LeukemiaOncologyMixed-phenotype Acute LeukemiaMalignant Blood Disorder +9